중동 및 아프리카 뇌졸중 진단 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 중동 및 아프리카 뇌졸중 진단 시장

중동 및 아프리카 뇌졸중 진단 시장은 2021년에서 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년에서 2028년까지의 예측 기간 동안 4.7%의 CAGR로 성장하고 있으며 2028년까지 2억 2,227만 달러에 도달할 것으로 예상한다고 분석합니다. 가처분 소득 증가와 신제품 개발 증가는 예측 기간 동안 시장 수요를 촉진할 것으로 예상되는 주요 원동력입니다. 그러나 팬데믹 동안 제한이 증가하면 시장이 제한될 수 있습니다.

뇌졸중은 뇌로 가는 혈액 공급이 감소하거나 완전히 차단되어 뇌 조직이 산소와 영양소를 얻지 못할 때 발생합니다. 뇌졸중과 그 초기 증상을 감지하는 데 사용되는 다양한 유형의 진단 장치가 있습니다. 예를 들어 컴퓨터 단층 촬영(CT SCAN), 컴퓨터 단층 혈관 조영술(CTA), 자기 공명 영상(MRI), 자기 공명 혈관 조영술(MRA), 경두개 도플러 초음파 등이 있습니다.

뇌졸중과 심혈관 및 신경계 질환의 증가로 인해 개발도상국에서 뇌졸중 진단에 대한 수요가 증가했습니다. 또한 의료비 지출이 증가하면서 시장 성장이 촉진되고 있습니다. 반면에 진단 비용이 높으면 시장 성장이 방해받을 수 있습니다. 시장 참여자의 존재와 신제품 출시는 기회를 제공하고 있습니다. 그러나 숙련된 전문가의 부족은 시장에 도전이 될 수 있습니다.

뇌졸중 진단 시장 보고서는 시장 점유율, 새로운 개발, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 기회 분석에 대한 세부 정보를 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 당사에 문의하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.

중동 및 아프리카 뇌졸중 진단 시장 범위 및 시장 규모

The Middle East and Africa stroke diagnostics market is segmented on the basis of severity, type, application, end user, distribution channel, and stage.

• On the basis of severity, the Middle East and Africa stroke diagnostics market is segmented into moderate, severe, and mild. In 2021, the moderate segment is expected to dominate the market, with an increase in the increasing awareness regarding stroke and early diagnosis.
• On the basis of type, the Middle East and Africa stroke diagnostics market is segmented into computed tomography (CT Scan), computed tomography angiography (CTA), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), transcranial Doppler ultrasound, video head impulse test (VHIT), other. In 2021, the computed tomography (CT scan) segment is expected to dominate the market with the increasing government initiatives to provide a better diagnosis.
• On the basis of application, the Middle East and Africa stroke diagnostics market is segmented into an ischemic stroke, hemorrhagic stroke, and transient ischemic attacks (TIAS). In 2021, ischemic stroke is expected to dominate the market with favorable government regulations regarding diagnostic devices.
• On the basis of end-users, the Middle East and Africa stroke diagnostics market is segmented into hospitals, home healthcare, ambulatory surgical centers, and clinics. In 2021, the hospital segment is expected to dominate the market due to the increasing healthcare expenditure and advancement in hospital facilities.
• On the basis of distribution channel, the Middle East and Africa stroke diagnostics market is segmented into direct tender, third party distributor, and others. In 2021, direct tender is expected to dominate the market due to the direct link of the manufacturer to the customers.
• On the basis of stages, the Middle East and Africa stroke diagnostics market is segmented into pre-operative, peri-operative, and post-operative. In 2021, pre-operative is expected to dominate the market due to the increasing prevalence of heart disease.

Middle East and Africa Stroke Diagnostics Market Country Level Analysis

The Middle East and Africa stroke diagnostics market is analyzed, and market size information is provided on the basis of severity, type, application, end user, distribution channel, and stage.

The countries covered in the stroke diagnostics market report are South Africa, Saudi Arabia, and the rest of the Middle East and Africa.

The Middle East and Africa stroke diagnostics market is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of the increasing number of stroke diagnostics manufacturers and R&D activities. South Africa is expected to dominate the Middle East and Africa stroke diagnostics market due to an increase in the incidence of disease of cardiovascular diseases in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of the Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Rising New Product Development Are Boosting the Market Growth Of Stroke Diagnostics

The stroke diagnostics market also provides you with detailed market analysis for every country's growth in the stroke diagnostics industry with stroke diagnostics drugs sales, the impact of advancement in the Stroke diagnostics technology, and changes in regulatory scenarios with their support for the Stroke diagnostics market. The data is available for the historic period 2011 to 2019.

Competitive Landscape and Stroke diagnostics Market Share Analysis

Stroke diagnostics market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to the stroke diagnostics market.

The major companies which are dealing in the Middle East and Africa stroke diagnostics market are Siemens, Koninklijke Philips N.V.,  General Electric Company,  Shenzhen Mindray Bio-Medical Electronics Co., Ltd., FUJIFILM Holdings Corporation, Analogic Corporation, Aspect Imaging Ltd, Carestream Health, ESAOTE SPA, Hologic, Inc., IMRIS, Deerfield Imaging Inc., MEDTRON AG, Neusoft Corporation, SAMSUNG, Shenzhen Anke High-Tech CO., Ltd., Shimadzu Corporation, SternMed GmbH, Stryker, among others.

Many product launches and agreements are also initiated by companies worldwide, which also accelerates the stroke diagnostics market.

For instance,

• In May 2021, Shimadzu Corporation announced its joint research agreement with Washington University School of Medicine in St. Louis to apply mass spectrometry technology toward the development of new products. It will enhance the company's R&D activities
• 2020년 11월, Stryker는 전 세계적으로 사지와 생물학에 중점을 둔 의료 기기 회사인 Wright Medical Group NV를 인수했다고 발표했습니다. 이 회사가 인수한 덕분에 회사의 제품 포트폴리오가 늘어나 향후 판매와 제품 수요가 증가했습니다.

협력, 제품 출시, 사업 확장, 수상 및 인정, 합작 투자 및 시장 참여자의 기타 전략은 뇌졸중 진단 시장에서 회사 시장을 강화하고 있으며, 이를 통해 조직이 뇌졸중 진단에 대한 제공 사항을 개선하는 데에도 도움이 됩니다.

SKU-66142